🇺🇸 FDA
Patent

US 9980936

BH4 antagonists and methods related thereto

granted A61KA61K31/122A61K31/336

Quick answer

US patent 9980936 (BH4 antagonists and methods related thereto) held by The Board of Regents of the University of Texas System expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/122, A61K31/336, A61K31/436, A61K31/439